2023
DOI: 10.1016/j.addr.2023.114869
|View full text |Cite
|
Sign up to set email alerts
|

Ocular immunosuppressive microenvironment and novel drug delivery for control of uveitis

Sean Teabagy,
Emma Wood,
Evan Bilsbury
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 111 publications
0
1
0
Order By: Relevance
“…[31] Although Adalimumab confers greater advantages than corticosteroids, systemic treatment or intravitreal injection of the drug carries significant risks such as immunosuppression or retinal detachment. [52] In addition, patients are often reluctant to receive such invasive treatment to the eye, resulting in low treatment efficacy. In the present study, the researchers aimed to provide a non-invasive therapy that can achieve a high Adalimumab permeation rate.…”
Section: Uveitismentioning
confidence: 99%
“…[31] Although Adalimumab confers greater advantages than corticosteroids, systemic treatment or intravitreal injection of the drug carries significant risks such as immunosuppression or retinal detachment. [52] In addition, patients are often reluctant to receive such invasive treatment to the eye, resulting in low treatment efficacy. In the present study, the researchers aimed to provide a non-invasive therapy that can achieve a high Adalimumab permeation rate.…”
Section: Uveitismentioning
confidence: 99%